| Interleukin6 | 6307 | Interleukin6 |
| 2008 1 | Roles of IL-6-gp130 Signaling in Vascular Inflammation. [19936194] Curr Cardiol Rev 4(3):179-92 (2008) |
| 2005 2 | Directing transition from innate to acquired immunity: defining a role for IL-6. [16148087] J Immunol 175(6):3463-8 (2005) |
| 2006 3 | Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. [16707558] J Leukoc Biol 80(2):227-36 (2006) |
| 2006 4 | Interleukin-6 trans-signalling in chronic inflammation and cancer. [16640655] Scand J Immunol 63(5):321-9 (2006) |
| 2003 5 | Interleukin-6 biology is coordinated by membrane bound and soluble receptors. [14515143] Acta Biochim Pol 50(3):603-11 (2003) |
| 1996 6 | Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? [8916880] Ann Surg 224(5):647-64 (1996) |
| 2007 7 | Decomposition of diverse litter mixtures in streams. [17489470] Ecology 88(1):219-27 (2007) |
| 2003 8 | Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. [14581334] Clin Cancer Res 9(13):4653-65 (2003) |
| 1989 9 | The biology of interleukin-6. [2473791] Blood 74(1):1-10 (1989) |
| 2010 10 | Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. [19854855] Rheumatology (Oxford) 49(1):15-24 (2010) |
| 2006 11 | Interleukin-6 and rheumatic diseases. [16899108] Arthritis Res Ther 8 Suppl 2(-):S4 (2006) |
| 2010 12 | The soluble interleukin 6 receptor takes its place in the pantheon of interleukin 6 signaling proteins: phenoconversion of cardiac fibroblasts to myofibroblasts. [20606105] Hypertension 56(2):193-5 (2010) |
| 2010 13 | The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. [20202975] Cardiovasc Res 86(2):211-8 (2010) |
| 2011 14 | Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. [21881215] J Clin Invest 121(9):3375-83 (2011) |
| 2008 15 | Muscle as an endocrine organ: focus on muscle-derived interleukin-6. [18923185] Physiol Rev 88(4):1379-406 (2008) |
| 2002 16 | Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. [12205025] FASEB J 16(11):1335-47 (2002) |
| 2007 17 | Interleukin-6 and its receptor in cancer: implications for translational therapeutics. [17849470] Cancer 110(9):1911-28 (2007) |
| 2003 18 | Principles of interleukin (IL)-6-type cytokine signalling and its regulation. [12773095] Biochem J 374(Pt 1):1-20 (2003) |
| 2011 19 | Blocking the IL-6-STAT3 signaling pathway: potential liver cancer therapy. [21345134] Future Oncol 7(2):161-4 (2011) |
| 2010 20 | Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. [20689230] Proc Jpn Acad Ser B Phys Biol Sci 86(7):717-30 (2010) |
| 2005 21 | IL-6 and extracellular matrix remodeling. [16266225] Rev Esp Enferm Dig 97(8):575-95 (2005) |
| 2002 22 | The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. [12055212] J Immunol 168(12):6041-6 (2002) |
| 2005 23 | Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. [15585417] Mol Ther 11(1):160-72 (2005) |
| 2011 24 | C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation. [21330607] Arterioscler Thromb Vasc Biol 31(5):1124-32 (2011) |
| 2011 25 | Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxynonenal and 4-oxononenal analogues. [21291287] Chem Res Toxicol 24(3):357-70 (2011) |
| 2010 26 | Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. [21116333] Drug Des Devel Ther 4(-):263-78 (2010) |
| 2011 27 | Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. [21625400] Cancer Manag Res 3(-):177-89 (2011) |
| 2010 28 | Interleukin-6 in bone metastasis and cancer progression. [20335016] Eur J Cancer 46(7):1223-31 (2010) |
| 2004 29 | Rationale for interleukin-6 blockade in systemic lupus erythematosus. [15230289] Lupus 13(5):339-43 (2004) |
| 2011 30 | Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. [21196778] Nephron Physiol 118(2):45-51 (2011) |
| 2004 31 | Interleukin-6 and cardiovascular diseases. [15090695] Jpn Heart J 45(2):183-93 (2004) |
| 2007 32 | Essential role of IL-6 signaling pathway in keloid pathogenesis. [17384473] J Nihon Med Sch 74(1):11-22 (2007) |
| 2010 33 | n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. [20189790] Prostaglandins Leukot Essent Fatty Acids 82(4-6):251-8 (2010) |
Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth
All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.